Huafang Li

发表

Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study

Huafang Li, Ting Li, Yan Li, 2013, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics

Luyao He, Huafang Li, Lu-jin Li, 2022, Journal of clinical psychopharmacology.

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study

Hongyan Zhang, Yanning Liu, Gang Wang, 2016, Neuropsychiatric disease and treatment.

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia

Huafang Li, Yifeng Shen, Wenjuan Yu, 2019, General Psychiatry.

Network-based approach to identify molecular signatures in the brains of depressed suicides

Weichen Song, Huafang Li, Yifeng Shen, 2020, Psychiatry Research.

General Information on Clinical Psychopharmacology in China.

Huafang Li, Yifeng Shen, 2018, Journal of clinical psychopharmacology.

The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder.

Huafang Li, Jihan Huang, Juan Yang, 2019, Journal of child and adolescent psychopharmacology.

Association between Tumor Necrosis factor-Alpha(TNF-a) polymorphisms and Schizophrenia: an updated meta-analysis

Huafang Li, Shun-ying Yu, Lei Zhang, 2022, International journal of psychiatry in clinical practice.

The influence of polymorphisms in TNIK gene on risperidone response in a Chinese Han population.

Shengying Qin, Huafang Li, Shun-ying Yu, 2022, Pharmacogenomics.

The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial

Huafang Li, Yan Li, Q. Zheng, 2021, Trials.

Reactive Transformation and Increased BDNF Signaling by Hippocampal Astrocytes in Response to MK-801

Yueming Wang, Hao Zhu, Huafang Li, 2015, PloS one.

Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial

Hongyan Zhang, Kerang Zhang, Jingwei Tian, 2021, The international journal of neuropsychopharmacology.

Quantitative analysis of the placebo response in pharmacotherapy of insomnia and its application in clinical trials.

Huafang Li, Yifeng Shen, Yingchun He, 2019, Sleep.

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids

Huafang Li, Yifeng Shen, Guan-jun Li, 2020, General Psychiatry.

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

M. Mathews, Huafang Li, Yan Li, 2018, Neuropsychiatric disease and treatment.

Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.

Chuanyue Wang, Qiang Wang, Huafang Li, 2015, Journal of psychiatric research.

Pharmacokinetics, Safety, and Tolerability of Lamotrigine Chewable/Dispersible Tablet Following Repeat‐Dose Administration in Healthy Chinese Volunteers

Yanmei Xu, Huafang Li, Yan Li, 2018, Clinical pharmacology in drug development.

Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study

Huafang Li, Zuoquan Xie, Jing Zhang, 2022, BMJ Open.

Model‐based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double‐blind study

Huafang Li, Yan Li, Yifeng Shen, 2019, Human psychopharmacology.

Correlation of hair risperidone concentration and serum level among patients with schizophrenia

Chen Zhang, Chunbo Li, Huafang Li, 2019, General Psychiatry.

Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers

Huafang Li, Yan Li, Jinhua Zhong, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder

Jie Ying Gao, Huafang Li, Yifeng Shen, 2021, Frontiers in Molecular Neuroscience.

Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder.

Y. Fang, Huafang Li, K. Jiang, 2016, Journal of psychiatric research.

Expression alteration of microRNAs in Nucleus Accumbens is associated with chronic stress and antidepressant treatment in rats

Xia Li, Guan Ning Lin, Weichen Song, 2019, BMC Medical Informatics Decis. Mak..

Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study

Huafang Li, Yifeng Shen, Shun-ying Yu, 2022, Frontiers in Psychiatry.

Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial

Huafang Li, Hao Yu, Yi-feng Shen, 2018, Journal of clinical psychopharmacology.

Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study

Huafang Li, Binggen Zhu, Lei Zhang, 2023, Frontiers in Pharmacology.

Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.

Chia-Chen Liu, S. Xiao, Huafang Li, 2015, Journal of affective disorders.

Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression

Huafang Li, Yifeng Shen, Jihan Huang, 2019, The international journal of neuropsychopharmacology.

Two Novel Loci of RELN Associated With Antipsychotics Response in Chinese Han Population

Shengying Qin, Huafang Li, Shun-ying Yu, 2020, Frontiers in Pharmacology.

Quantifying placebo responses in clinical evaluation of neuropsychiatric symptoms in Alzheimer’s disease

Huafang Li, Y. Lv, Junchao Chen, 2019, European Journal of Clinical Pharmacology.

Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia

Huafang Li, Yifeng Shen, Lei Zhang, 2021, BMC Psychiatry.

The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder

Huafang Li, K. Jiang, Q. Guo, 2021, Neuroscience Letters.

Co-Expression Network Analysis Revealed That the ATP5G1 Gene Is Associated With Major Depressive Disorder

Huafang Li, Yifeng Shen, Changling Ma, 2019, Front. Genet..

Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study

G. Wang, Huafang Li, Cui Ma, 2008, Current medical research and opinion.

Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder

Y. Fang, Huafang Li, K. Jiang, 2014, Neuroscience Letters.

Efficacy of huadananshen mistura on insomnia: a randomized, double-blind, placebo-controlled, and multi-center clinical trial.

Huafang Li, Ting Li, Qiaochu Wang, 2013, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

Signatures of 4 autophagy-related genes as diagnostic markers of MDD and their correlation with immune infiltration.

Huafang Li, D. Peng, Tian Li, 2021, Journal of affective disorders.

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia

Q. Rui, Huafang Li, X. Ning, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study

Huafang Li, Yan Li, Yan Liu, 2012, Current medical research and opinion.

Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai

Huafang Li, M. Good, Y. Shao, 2018, Neuropsychiatric disease and treatment.

Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial

Hongyan Zhang, Lingjiang Li, Kerang Zhang, 2016, Psychopharmacology.

Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS

Luyao He, Huafang Li, Yifeng Shen, 2022, Frontiers in Pharmacology.

Reversible Changes in BDNF Expression in MK-801-Induced Hippocampal Astrocytes Through NMDAR/PI3K/ERK Signaling

Hao Zhu, Huafang Li, Lei Zhang, 2021, Frontiers in Cellular Neuroscience.

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder

Jianfeng Luo, Huafang Li, Yifeng Shen, 2017, Medicine.

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study

Huafang Li, Yifeng Shen, Lei Zhang, 2021, Neuropsychiatric disease and treatment.

The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study

Huafang Li, Guan-jun Li, Yimin Fan, 2021, International clinical psychopharmacology.

Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial.

Xiufeng Xu, Yunlong Tan, Huafang Li, 2019, Journal of affective disorders.

Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers

Huafang Li, Yan Li, Fan Zhang, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Ethics, patient rights and staff attitudes in Shanghai's psychiatric hospitals

L. Su, Huafang Li, Yifeng Shen, 2012, BMC medical ethics.

Inhibition of iNOS ameliorates traumatic stress-induced deficits in synaptic plasticity and memory

Huafang Li, Xiaoliang Wang, Huifang Wang, 2018, Psychiatry Research.

Huafang Li, Yifeng Shen, Lei Zhang, 2021, General Psychiatry.

Characteristics of Chinese women in need of enhanced sexual health attention and at risk of hypoactive sexual desire disorder

Huafang Li, Jingjing Huang, Lan Luo, 2023, BMC Women's Health.

The e cacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial

Huafang Li, Yifeng Shen, Q. Zheng, 2021 .

Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial

J. Kane, Xiufeng Xu, Chuanyue Wang, 2014, Schizophrenia Research.

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia

Hongyan Zhang, Gang Wang, Huafang Li, 2011, Neuropsychiatric disease and treatment.

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China

Luyao He, Huafang Li, Yifeng Shen, 2022, Frontiers in Pharmacology.

Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients

Lei Zhang, Huafang Li, Yi-min Yu, 2016, Neuroscience Letters.

Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice.

Xiaoyun Guo, Huafang Li, Shun-ying Yu, 2012, Biochimica et biophysica acta.

miR-124 Exacerbates depressive-like behavior by targeting Ezh2 to induce autophagy

Huafang Li, Shen He, Yue Shi, 2022, Behavioural pharmacology.

Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial

Xiufeng Xu, Gang Wang, Huafang Li, 2015, Shanghai archives of psychiatry.

Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults

Huafang Li, Yan Li, Peiming Ma, 2018, Clinical pharmacology in drug development.

Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study

Huafang Li, I. Turkoz, Fan Zhang, 2015, Neuropsychiatric disease and treatment.

A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder

Kerang Zhang, Yiming Wang, Jingwei Tian, 2023, Translational psychiatry.

Plasma biomarker panel for major depressive disorder by quantitative proteomics using ensemble learning algorithm: A preliminary study

Huafang Li, Yan Li, Jingjing Huang, 2023, Psychiatry Research.

Original article Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study

Huafang Li, Yan Li, Yan Liu, 2012 .

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response

Huafang Li, Yifeng Shen, Changling Ma, 2018, Neuropsychiatric disease and treatment.

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China

Huafang Li, Yan Li, Lei Zhang, 2019, Acta Pharmacologica Sinica.

Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects

Hongyan Zhang, T. Si, Q. Rui, 2014, Human psychopharmacology.

SOX10 rs139883 Polymorphism Is Associated with the Age of Onset in Schizophrenia

Chen Zhang, Yifeng Xu, Dengtang Liu, 2013, Journal of Molecular Neuroscience.

Quantifying placebo responses in clinical evaluation of neuropsychiatric symptoms in Alzheimer’s disease

Huafang Li, Y. Lv, Junchao Chen, 2019, European Journal of Clinical Pharmacology.

A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes

Xiufeng Xu, Gang Wang, Huafang Li, 2018, Psychiatry Research.

Genome-Wide miRNA Expression Alterations in Nucleus Accumbens Provide Insights into Chronic Stress and Treatment in Depression

Guan Ning Lin, Yanhua Zhang, Sufang Peng, 2018, 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteers

Huafang Li, Chunrong Wang, Jiansong Yang, 2015, Clinical pharmacology in drug development.

Efficacy of Artificial Intelligence-Assisted Psychotherapy in Patients With Anxiety Disorders: A Prospective, National Multicenter Randomized Controlled Trial Protocol

Min Zhao, Huafang Li, Yanli Luo, 2022, Frontiers in Psychiatry.

Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder

Huafang Li, Zuoquan Xie, Jingjing Huang, 2024, Psychiatry Research.